rs1799801

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005236.3(ERCC4):​c.2505T>C​(p.Ser835Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.284 in 1,613,896 control chromosomes in the GnomAD database, including 66,188 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5045 hom., cov: 32)
Exomes 𝑓: 0.29 ( 61143 hom. )

Consequence

ERCC4
NM_005236.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -3.35

Publications

91 publications found
Variant links:
Genes affected
ERCC4 (HGNC:3436): (ERCC excision repair 4, endonuclease catalytic subunit) The protein encoded by this gene forms a complex with ERCC1 and is involved in the 5' incision made during nucleotide excision repair. This complex is a structure specific DNA repair endonuclease that interacts with EME1. Defects in this gene are a cause of xeroderma pigmentosum complementation group F (XP-F), or xeroderma pigmentosum VI (XP6).[provided by RefSeq, Mar 2009]
ERCC4 Gene-Disease associations (from GenCC):
  • xeroderma pigmentosum group F
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, ClinGen
  • Fanconi anemia complementation group Q
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • XFE progeroid syndrome
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • xeroderma pigmentosum
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • xeroderma pigmentosum-Cockayne syndrome complex
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 16-13948101-T-C is Benign according to our data. Variant chr16-13948101-T-C is described in ClinVar as Benign. ClinVar VariationId is 129007.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.35 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.292 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERCC4NM_005236.3 linkc.2505T>C p.Ser835Ser synonymous_variant Exon 11 of 11 ENST00000311895.8 NP_005227.1 Q92889-1A0A1W1GSK9
ERCC4XM_011522424.4 linkc.2643T>C p.Ser881Ser synonymous_variant Exon 12 of 12 XP_011520726.1 A0A804HKF9
ERCC4XM_047433774.1 linkc.1716T>C p.Ser572Ser synonymous_variant Exon 8 of 8 XP_047289730.1
ERCC4XM_011522427.2 linkc.1155T>C p.Ser385Ser synonymous_variant Exon 6 of 6 XP_011520729.1 B4DXD8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERCC4ENST00000311895.8 linkc.2505T>C p.Ser835Ser synonymous_variant Exon 11 of 11 1 NM_005236.3 ENSP00000310520.7 Q92889-1

Frequencies

GnomAD3 genomes
AF:
0.250
AC:
37968
AN:
151962
Hom.:
5036
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.174
Gnomad AMI
AF:
0.340
Gnomad AMR
AF:
0.249
Gnomad ASJ
AF:
0.305
Gnomad EAS
AF:
0.249
Gnomad SAS
AF:
0.302
Gnomad FIN
AF:
0.241
Gnomad MID
AF:
0.345
Gnomad NFE
AF:
0.288
Gnomad OTH
AF:
0.290
GnomAD2 exomes
AF:
0.272
AC:
68347
AN:
251224
AF XY:
0.279
show subpopulations
Gnomad AFR exome
AF:
0.173
Gnomad AMR exome
AF:
0.233
Gnomad ASJ exome
AF:
0.312
Gnomad EAS exome
AF:
0.240
Gnomad FIN exome
AF:
0.235
Gnomad NFE exome
AF:
0.294
Gnomad OTH exome
AF:
0.292
GnomAD4 exome
AF:
0.287
AC:
419607
AN:
1461816
Hom.:
61143
Cov.:
38
AF XY:
0.290
AC XY:
210714
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.169
AC:
5670
AN:
33480
American (AMR)
AF:
0.239
AC:
10668
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.313
AC:
8191
AN:
26136
East Asian (EAS)
AF:
0.235
AC:
9330
AN:
39698
South Asian (SAS)
AF:
0.318
AC:
27429
AN:
86256
European-Finnish (FIN)
AF:
0.238
AC:
12699
AN:
53418
Middle Eastern (MID)
AF:
0.374
AC:
2158
AN:
5768
European-Non Finnish (NFE)
AF:
0.294
AC:
326454
AN:
1111954
Other (OTH)
AF:
0.282
AC:
17008
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
18928
37856
56785
75713
94641
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10810
21620
32430
43240
54050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.250
AC:
38007
AN:
152080
Hom.:
5045
Cov.:
32
AF XY:
0.248
AC XY:
18465
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.174
AC:
7216
AN:
41482
American (AMR)
AF:
0.249
AC:
3810
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.305
AC:
1059
AN:
3472
East Asian (EAS)
AF:
0.249
AC:
1288
AN:
5172
South Asian (SAS)
AF:
0.305
AC:
1465
AN:
4810
European-Finnish (FIN)
AF:
0.241
AC:
2550
AN:
10576
Middle Eastern (MID)
AF:
0.344
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
0.288
AC:
19592
AN:
67974
Other (OTH)
AF:
0.292
AC:
616
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1425
2850
4274
5699
7124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
394
788
1182
1576
1970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.281
Hom.:
17391
Bravo
AF:
0.247
Asia WGS
AF:
0.304
AC:
1057
AN:
3478
EpiCase
AF:
0.305
EpiControl
AF:
0.299

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Xeroderma pigmentosum, group F Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Nov 22, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 26, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Cockayne syndrome;C0268140:Xeroderma pigmentosum, group F;C3808988:Fanconi anemia complementation group Q Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

XFE progeroid syndrome Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fanconi anemia complementation group Q Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.13
DANN
Benign
0.45
PhyloP100
-3.3
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1799801; hg19: chr16-14041958; COSMIC: COSV61310532; COSMIC: COSV61310532; API